2026武汉医药研发与生产外包服务展落地API China，打造CRO/CDMO产业对接高地

2026 年 11 月 11‑13 日，2026 武汉医药研发与生产外包服务展将在武汉国际博览中心隆重举办，作为第 95 届 API China 中国国际医药原料药交易会的核心专题展区，本次展会聚焦 CRO、CDMO、CMO 全链条外包服务，为创新药企业、MAH 持证主体、生物科技公司搭建研发、受托生产、商务合作的专业化对接平台。

November 11‑13, 2026, Wuhan, China — The 2026 Wuhan Pharmaceutical R&D and Manufacturing Outsourcing Exhibition, a key special zone of the 95th API China (China International API, Intermediates, Packaging & Equipment Fair), will open at Wuhan International Expo Center. It creates a professional docking platform for CRO, CDMO and CMO services, serving innovative drug enterprises, MAH license holders and biotech companies across the country.

当前国内创新药产业快速发展，新药研发管线持续扩容，MAH 制度深度落地，医药研发与生产外包（CXO）成为制药产业降本增效、加速新药商业化的关键支撑。本次武汉 CRO CDMO CMO 展会立足中部医药产业区位优势，汇聚国内头部外包服务商、工艺开发企业、合规咨询机构，覆盖药物发现、临床前研究、临床试验、注册申报、原料药及制剂受托生产、生物药工艺放大、高端复杂制剂代工等完整业务板块。

Driven by the booming domestic innovative drug sector and deep implementation of the MAH system, pharmaceutical R&D and manufacturing outsourcing (CXO) plays an essential role in cutting R&D costs and accelerating new‑drug commercialization. This CRO CDMO CMO exhibition in Wuhan gathers leading outsourcing service providers and process‑development enterprises, covering drug discovery, pre‑clinical research, clinical trials, regulatory filing, API & formulation contract manufacturing, biopharma process scaling‑up and high‑end complex formulation contract production.

本届展会与 SINOPHEX 制药设备展、PHARMPACK 医药包装展、PHARMEX 药用辅料展五大主题展同馆联动，整体展览面积 80000 平方米，汇聚 2000 余家海内外参展企业，预计吸引 12 万 + 专业观众到场。除企业展示之外，现场配套多场高价值产业活动，包含 CRO/CDMO 创新药产业对接会、MAH 受托合作专场、医药出海与海外注册合规论坛、生物药工艺开发研讨会，同时开设一对一特邀买家匹配、国际采购对接环节，打通 “技术展示‑论坛交流‑商务洽谈” 全链路。

Co‑located with SINOPHEX Pharma Equipment Show, PHARMPACK Pharmaceutical Packaging Show and PHARMEX Pharmaceutical Excipients Show, the total exhibition area reaches 80,000 ㎡ with more than 2,000 exhibitors and an expected 120,000 professional visitors. A rich agenda of supporting events will be staged on‑site, including CRO/CDMO innovation‑drug matchmaking sessions, MAH entrusted‑production special forums, pharmaceutical overseas registration seminars, biopharmaceutical process development workshops, as well as one‑on‑one buyer‑supplier matching and international procurement meetings.

参展企业将带来小分子药物、多肽、核酸、抗体药物、细胞基因治疗等前沿领域外包解决方案，同时展示实验室研发平台、工艺中试放大、质量合规管控、知识产权服务、医药产业园区配套等上下游资源。来自全国各地制药工业、创新药企、研究院所、投资机构、医药产业园的专业观众，可一站式完成服务商筛选、技术交流与项目洽谈，高效对接医药外包全产业链资源。

Exhibitors will present comprehensive outsourcing solutions for small‑molecule drugs, peptides, nucleic acids, antibodies and cell & gene therapies. Related supporting resources including laboratory R&D platforms, pilot‑scale process amplification, quality compliance management, intellectual property consultation and pharmaceutical industrial park services will also be displayed. Professional visitors from pharmaceutical manufacturers, biotech startups, research institutes, investment institutions and industrial parks can realize one‑stop supplier screening, technical exchange and project negotiation.

作为中部地区极具影响力的医药外包服务展会，2026 武汉医药研发与生产外包服务展依托 API China 成熟行业资源，将进一步打通国内创新药研发生产协作通道，助力医药企业缩短研发周期、降低产业化门槛，推动中部医药产业集群高质量发展。展会目前招展工作有序推进，欢迎医药外包服务商、制药企业及产业链相关单位积极参与，共探行业新机遇。

As one of the most influential pharmaceutical outsourcing service expo in central China, the 2026 Wuhan Pharmaceutical R&D and Manufacturing Outsourcing Exhibition leverages the industrial resources of API China to boost collaboration within the whole pharmaceutical innovation chain. It helps pharmaceutical enterprises shorten R&D cycles and lower industrialization barriers, promoting high‑quality development of the central‑China pharmaceutical cluster. Booth recruitment is now in progress. Service providers, pharmaceutical manufacturers and industrial‑chain partners are welcome to participate and explore new business opportunities.